Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population-Reference-Cited by-同舟云学术

Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population

Published:2017-11-01 Issue:11 Volume:28 Page:2747-2755
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Benasutti Halli¹,Wang Guankui¹,Vu Vivian P.¹,Scheinman Robert¹,Groman Ernest¹,Saba Laura¹,Simberg Dmitri¹^ORCID

Affiliation:

1. Translational Bio-Nanosciences Laboratory, ‡Colorado Center for Nanomedicine and Nanosafety, §The Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, ∥Systems Genetics and Bioinformatics Laboratory, and ⊥Center for Translational Pharmacokinetics and Pharmacogenomics, University of Colorado Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, Colorado 80045, United States

Funder

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.7b00496

Reference48 articles.

1. Approaching the Asymptote? Evolution and Revolution in Immunology

2. Complement and its role in innate and adaptive immune responses